Dr. Vadim Jucaud's lab at the Terasaki Institute has developed a human vascularized liver cancer-on-a-chip model to evaluate vessel remodeling and cell death in response to embolic agents. This novel ...

A new microfluidic technology that leverages immune cell behavior is set to transform cancer monitoring, thanks to ...

For a little over two decades, chimeric antigen receptor (CAR) T cell therapy has emerged as a powerful new way to treat cancer. By extracting patients' T cells, re-engineering them to recognize tumor ...

Researchers at Penn have published a study utilizing “tumor-on-a-chip” devices to explore potential cancer treatments and develop new models. The research team included multiple students and faculty ...

Abstract Cancer progression involves cell adhesion molecules (CAMs), which facilitate the recruitment of leukocytes and metastatic tumor cells to ...

Los Angeles, CA – September 3, 2025 - Dr. Vadim Jucaud's lab at the Terasaki Institute has developed a human vascularized liver cancer-on-a-chip model to evaluate vessel remodeling and cell death in ...

Researchers used sophisticated molecular tagging systems in mouse models of brain, lung, and pancreatic cancer to directly ...

UCLA and Stanford Medicine researchers, in collaboration with scientists from the University of Utah and Columbia University, ...